1.2.3 Polio 1.2.4 Hepatitis A 1.2.5 Rabies 1.2.6 BCG 1.2.7 Hepatitis B 1.2.8 Pertussis , Diphtheria , tetanus 1.2.9 Pneumococcal 1.2.10 Other 1.3 Market Analysis by Applications 1.3.1 For Adult 1.3.2 For Child 1.4 Market Analysis by Regions 1.4.1 North America ( USA , Canada and Mexico ) 1.4.1.1 USA Market States and Outlook ( 2012-2022 ) 1.4.1.2 Canada Market States and Outlook ( 2012-2022 ) 1.4.1.3 Mexico Market States and Outlook ( 2012-2022 ) 1.4.2 Europe ( Germany , France , UK , Russia and Italy ) 1.4.2.1 Germany Market States and Outlook ( 2012-2022 ) 1.4.2.2 France Market States and Outlook ( 2012-2022 ) 1.4.2.3 UK Market States and Outlook ( 2012-2022 ) 1.4.2.4 Russia Market States and Outlook ( 2012-2022 ) 1.4.2.5 Italy Market States and Outlook ( 2012-2022 ) 1.4.3 Asia-Pacific ( China , Japan , Korea , India and Southeast Asia ) 1.4.3.1 China Market States and Outlook ( 2012-2022 ) 1.4.3.2 Japan Market States and Outlook ( 2012-2022 ) 1.4.3.3 Korea Market States and Outlook ( 2012-2022 ) 1.4.3.4 India Market States and Outlook ( 2012-2022 ) 1.4.3.5 Southeast Asia Market States and Outlook ( 2012-2022 ) 1.4.4 South America , Middle East and Africa 1.4.4.1 Brazil Market States and Outlook ( 2012-2022 ) 1.4.4.2 Egypt Market States and Outlook ( 2012-2022 ) 1.4.4.3 Saudi Arabia Market States and Outlook ( 2012-2022 ) 1.4.4.4 South Africa Market States and Outlook ( 2012-2022 ) 1.4.4.5 Nigeria Market States and Outlook ( 2012-2022 ) 1.5 Market Dynamics 1.5.1 Market Opportunities 1.5.2 Market Risk 1.5.3 Market Driving Force 2 Manufacturers Profiles 2.1 CNBG 2.1.1 Business Overview 2.1.2 All Vaccine Type and Applications 2.1.2.1 Type 1 2.1.2.2 Type 2 2.1.3 CNBG All Vaccine Sales , Price , Revenue , Gross Margin and Market Share ( 2016-2017 ) 2.2 ChengDa Bio 2.2.1 Business Overview 2.2.2 All Vaccine Type and Applications 2.2.2.1 Type 1 2.2.2.2 Type 2